Search results for "Heart"

showing 10 items of 3201 documents

Empagliflozin in heart failure with preserved ejection fraction: decoding its molecular mechanism of action using artificial intelligence

2021

Abstract   Rationale The use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) to treat heart failure with preserved ejection fraction (HFpEF) is under investigation in ongoing clinical trials, but the exact mechanism of action is unclear. Here we aimed to use artificial intelligence (AI) to characterize the mechanism of action of empagliflozin in HFpEF at the molecular level. Methods We retrieved information regarding HFpEF pathophysiological motifs and differentially expressed genes/proteins, together with empagliflozin target information and bioflags, from specialized publicly available databases. Artificial neural networks and deep learning AI were used to model the molecular effec…

medicine.medical_specialtyAction (philosophy)business.industryInternal medicineEmpagliflozinmedicineMolecular mechanismCardiologyCardiology and Cardiovascular MedicinebusinessHeart failure with preserved ejection fractionDecoding methodsEuropean Heart Journal
researchProduct

A late diagnosis of aortic coarctation began as an acute coronary syndrome

2014

Abstract Aortic coarctation accounts the 5%–10% of congenital heart disease. It is usually diagnosed during childhood but the postductal form is most common in adults and may be diagnosed incidentally in the context of investigation for hypertension. The age of correction is the most important factor for the relief of hypertension and long-term survival. We describe a case of a 63-year-old man, came to our emergency room for acute coronary syndrome. Cardiac catheterization with right femoral artery access was performed but for many difficulties during the introduction of catheters was therefore performed aortography that showed an interruption "a cul de sac" at the level of the descending t…

medicine.medical_specialtyAcute coronary syndromeAortographyRight femoral arterymedicine.diagnostic_testHeart diseasebusiness.industrymedicine.medical_treatmentContext (language use)medicine.diseaseSurgeryLate diagnosisInternal medicinemedicine.arterymedicineCardiologyThoracic aortabusinessCardiac catheterizationJournal of Indian College of Cardiology
researchProduct

Management of Pulmonary Embolism: Results from the German Chest Pain Unit Registry.

2020

<b><i>Introduction:</i></b> Since 2008, specialized chest pain units (CPUs) were implemented across Germany ensuring structured diagnostics in acute chest pain. This study aims to analyze the management of pulmonary embolism (PE) patients in such certified CPUs. <b><i>Methods:</i></b> Data were retrieved from 13,902 patients enrolled in the German CPU registry and analyzed for the diagnosis of PE including patient characteristics, critical time intervals, diagnostic workup, treatment, and prognosis. PE patients were compared to the overall CPU patient cohort. Only patients with a complete 3-month follow-up were included. <b><i>Resu…

medicine.medical_specialtyAcute coronary syndromeChest PainMedizinChest painlaw.inventionlawGermanyAcute chest painmedicineHumansPharmacology (medical)RegistriesAcute Coronary Syndromebusiness.industrymedicine.diseaseIntensive care unitPulmonary embolismHeart failureEmergency medicineCohortDifferential diagnosismedicine.symptomCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismCardiology
researchProduct

Predicting mortality with cardiac troponins: recent insights from meta-analyses.

2019

Abstract The introduction of cardiac troponin (cTn) testing in clinical practice has been one of the most important breakthroughs that have occurred in the recent history of laboratory medicine. Although it is now uncontestable that cTn values are essential for diagnosing acute coronary syndrome (ACS), solid evidence is also emerging that assessment of either cardiac troponin I (cTnI) or T (cTnT) may provide valuable prognostic information in the general healthy population, as well as in patients with a vast array of cardiac and extra-cardiac diseases. We have hence performed a critical review of the scientific literature for identifying meta-analyses which have investigated the potential c…

medicine.medical_specialtyAcute coronary syndromeClinical BiochemistryPopulationMedicine (miscellaneous)Disease030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciences0302 clinical medicinedeath; mortality; prediction; troponinTroponin complexMeta-Analysis as TopicTroponin TInternal medicinedeathTroponin ImedicineHumans030212 general & internal medicineAcute Coronary Syndromeeducationeducation.field_of_studybiologybusiness.industrytroponinHealth PolicyBiochemistry (medical)Troponin IPublic Health Environmental and Occupational Healthpredictionmedicine.diseasePrognosisTroponinmortalityHeart failurebiology.proteinCardiologybusinessDiagnosis (Berlin, Germany)References
researchProduct

Update on Ischemic Heart Disease and Critical Care Cardiology

2014

This article summarizes the main developments reported in 2013 on ischemic heart disease, together with the most important innovations in the management of acute cardiac patients. 3.792 JCR (2014) Q2, 34/123 Cardiac & cardiovascular systems UEM

medicine.medical_specialtyAcute coronary syndromeCritical Caremedicine.medical_treatmentEnfermedad cardiovascularMyocardial InfarctionMyocardial IschemiaDiseaseCardiologíaTratamiento médicoPercutaneous Coronary InterventionSex FactorsSex factorsInternal medicinemedicineHumansMyocardial infarctionAcute Coronary SyndromeIntensive care medicinePatofisiologíaSistema cardiovascularbusiness.industryAge FactorsPercutaneous coronary interventionGeneral Medicinemedicine.diseasePrognosisPrimary PreventionConventional PCICardiologycardiovascular systemPlatelet aggregation inhibitorInfarto de miocardiobusinessIschemic heartPlatelet Aggregation InhibitorsRevista Española de Cardiología (English Edition)
researchProduct

Acute Coronary Syndrome in the Older Patient

2021

Coronary artery disease is one of the leading causes of morbidity and mortality, and its prevalence increases with age. The growing number of older patients and their differential characteristics make its management a challenge in clinical practice. The aim of this review is to summarize the state-of-the-art in diagnosis and treatment of acute coronary syndromes in this subgroup of patients. This comprises peculiarities of ST-segment elevation myocardial infarction (STEMI) management, updated evidence of non-STEMI therapeutic strategies, individualization of antiplatelet treatment (weighting ischemic and hemorrhagic risks), as well as assessment of geriatric conditions and ethical issues in…

medicine.medical_specialtyAcute coronary syndromeInfarto del miocardio con elevación del STEnfermedad cardiovascularAncianoReviewCardiologíaMalalties coronàrieselderlyPersones gransacute coronary syndromeCoronary artery diseaseOlder patientsInfarto del miocardio sin elevación del STInternal medicineMedicineSíndrome coronario agudoMyocardial infarctioncardiovascular diseasesEthical issuesbusiness.industryRGeneral Medicinemedicine.diseaseClinical PracticeCoronary heart diseasemyocardial infarctionCardiologyMedicineOlder peoplebusinessJournal of Clinical Medicine
researchProduct

Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome

2021

Ischemic heart disease (IHD) persists as the leading cause of death in the Western world. In recent decades, great headway has been made in reducing mortality due to IHD, based around secondary prevention. The advent of coronary revascularization techniques, first coronary artery bypass grafting (CABG) surgery in the 1960s and then percutaneous coronary intervention (PCI) in the 1970s, has represented one of the major breakthroughs in medicine during the last century. The benefit provided by these techniques, especially PCI, has been crucial in lowering mortality rates in acute coronary syndrome (ACS). However, in the setting where IHD is most prevalent, namely chronic coronary syndrome (CC…

medicine.medical_specialtyAcute coronary syndromeIschemic heart diseasemedicine.medical_treatmentstress cardiac magnetic resonancelcsh:MedicineChronic coronary syndromeReviewischemiaDisease030204 cardiovascular system & hematologyRevascularizationCoronary artery diseaseCoronary artery disease03 medical and health sciences0302 clinical medicineIschemiaInternal medicineMedicine030212 general & internal medicineCause of deathStress cardiac magnetic resonancechronic coronary syndromebusiness.industryMortality ratelcsh:RPercutaneous coronary interventionGeneral Medicinemedicine.diseaseischemic heart diseaseMyocardial revascularizationmyocardial revascularizationConventional PCICardiologybusinesscoronary artery diseaseJournal of Clinical Medicine
researchProduct

0349: Transfer of acute coronary syndrome patients in the Alps (SCA-Alpes). Data from the RESURCOR network

2016

RationaleIn France, the transfer of patients with an acute coronary syndrome (ACS) from one centre to another is usually done by SMUR, with on-board medical staff. However, SMUR is not always available. In this study from the RESURCOR network, we investigated clinical outcomes in ACS patients transferred in private ambulances without on-board medical staff.MethodIn the French Alps, the RESURCOR network arranges “SCAAlpes” transfers in private ambulances with no medical doctors on board but with non-medically trained staff who follow strict management protocols. Ambulances are equipped with an automatic external defibrillator and patients are not under heart monitoring. These transfers are f…

medicine.medical_specialtyAcute coronary syndromeMedical staffReferralbusiness.industrymedicine.medical_treatmentPercutaneous coronary interventionmedicine.diseaseHeart monitoringSudden deathConventional PCIEmergency medicinemedicineMedical emergencyMyocardial infarctionbusinessCardiology and Cardiovascular MedicineArchives of Cardiovascular Diseases Supplements
researchProduct

Speckle tracking analysis in intensive care unit: A toy or a tool?

2018

The use of conventional echocardiography in the intensive care unit (ICU) is today established to assess left and right ventricular systolic function, for preload determination and procedural guidance. Next step in ICU echocardiography could be the use of novel ultrasound techniques such as strain echocardiography to assist in the management of patients with acute coronary syndrome, heart failure, or pulmonary embolism. This review has gathered the available evidence supporting the incremental value of strain in the diagnostic workup of cardiac diseases treated in ICU.

medicine.medical_specialtyAcute coronary syndromeRadiology Nuclear Medicine and ImagingMyocarditispulmonary embolismCritical CareHeart Diseasespulmonaryhealth care facilities manpower and servicesspeckle tracking strainIntensive Care Unitheart failureacute coronary syndrome; heart failure; intensity care unit; myocarditis; pulmonary; pulmonary embolism; speckle tracking strain; Critical Care; Echocardiography; Heart; Heart Diseases; Humans; Intensive Care Unitsacute coronary syndrome; heart failure; intensity care unit; myocarditis; pulmonary; pulmonary embolism; speckle tracking strain; Critical Care; Echocardiography; Heart; Heart Diseases; Humans; Intensive Care Units; Radiology Nuclear Medicine and Imaging; Cardiology and Cardiovascular Medicine030204 cardiovascular system & hematologylaw.inventionacute coronary syndrome03 medical and health sciencesSpeckle pattern0302 clinical medicinelawNuclear Medicine and ImagingmedicineHumansintensity care unitSpeckle trackingbusiness.industry030208 emergency & critical care medicineHeartmedicine.diseaseIntensive care unitUltrasound techniquesPulmonary embolismPreloadIntensive Care UnitsHeart DiseaseEchocardiographymyocarditiHeart failureEmergency medicinemyocarditisbusinessRadiologyCardiology and Cardiovascular MedicineHuman
researchProduct

Up-and-Coming Markers: Myeloperoxidase, a Novel Biomarker Test for Heart Failure and Acute Coronary Syndrome Application?

2008

Myeloperoxidase (MPO) is a mammalian enzyme responsible for generation of hypochlorite. The advantage of myeloperoxidase for use as a biomarker in the setting of heart failure and acute coronary syndrome is the early increase of MPO concentration in response to the acute event. In the setting of heart failure the reported independency of coronary artery disease and general inflammation, as indicated by MPO concentration in comparison to other inflammatory markers or in subgroups of patients with ischemic and non-ischemic cardiomyopathy, has to be highlighted. In terms of ACS, inclusion of MPO into a multiple marker strategy might add to enhance diagnosis and therapy decision making. Therefo…

medicine.medical_specialtyAcute coronary syndromeanimal diseasesCardiomyopathyInflammationDiseaseEmergency NursingDiagnosis DifferentialCoronary artery diseaseInternal medicinemedicineHumansAcute Coronary SyndromePeroxidaseHeart Failurebiologybusiness.industrymedicine.diseaseMyeloperoxidaseHeart failurebiology.proteinCardiologyEmergency MedicineBiomarker (medicine)medicine.symptombusinessCardiology and Cardiovascular MedicineBiomarkersCongestive Heart Failure
researchProduct